Skip to main content

Articles

1199 result(s) for 'cancer' within Journal of Ovarian Research

Page 22 of 24

  1. Nuclear factor-kappa B (NF-kappaB) signaling is an important link between inflammation and peritoneal carcinomatosis in human ovarian cancer. Our objective was to track NF-kappaB signaling during ovarian cancer p...

    Authors: Andrew J Wilson, Whitney Barham, Jeanette Saskowski, Oleg Tikhomirov, Lianyi Chen, Hye-Jeong Lee, Fiona Yull and Dineo Khabele
    Citation: Journal of Ovarian Research 2013 6:63
  2. In assisted reproduction cycles, gonadotropins are administered to obtain a greater number of oocytes. A majority of patients do not have an adverse response; however, approximately 3-6% develop ovarian hypers...

    Authors: Evelin M Elia, Ramiro Quintana, Carlos Carrere, María V Bazzano, Gastón Rey-Valzacchi, Dante A Paz and María C Pustovrh
    Citation: Journal of Ovarian Research 2013 6:62
  3. Studies of alternative mRNA splicing (AS) in health and disease have yet to yield the complete picture of protein diversity and its role in physiology and pathology. Some forms of cancer appear to be associated t...

    Authors: Sergio Juárez-Méndez, Alejandro Zentella-Dehesa, Vanessa Villegas-Ruíz, Oscar Alberto Pérez-González, Mauricio Salcedo, Ricardo López-Romero, Edgar Román-Basaure, Minerva Lazos-Ochoa, Víctor Edén Montes de Oca-Fuentes, Guelaguetza Vázquez-Ortiz and José Moreno
    Citation: Journal of Ovarian Research 2013 6:61
  4. To ensure a correct interpretation of results obtained with quantitative real-time reverse transcription-polymerase chain reaction (RT-qPCR), it is critical to normalize to a reference gene with stable mRNA ex...

    Authors: Zuzana Kolkova, Arsen Arakelyan, Bertil Casslén, Stefan Hansson and Eva Kriegova
    Citation: Journal of Ovarian Research 2013 6:60
  5. To investigate the value of diffusion-weighted imaging (DWI) at 3.0 T (3T), and especially the apparent diffusion coefficient (ADC), in discriminating ovarian thecoma from other adnexal solid masses.

    Authors: He Zhang, Guo-Fu Zhang, Tian-Ping Wang and Hao Zhang
    Citation: Journal of Ovarian Research 2013 6:58
  6. The goal of this study was to determine a predominant cell type expressing fractalkine receptor (CX3CR1) in mature ovarian teratomas and to establish functional significance of its expression in cell differentiat...

    Authors: Lisa Rooper, Hilal Gurler, Andre A Kajdacsy-Balla and Maria V Barbolina
    Citation: Journal of Ovarian Research 2013 6:57
  7. We have earlier reported that follicle stimulating hormone (FSH) modulates ovarian stem cells which include pluripotent, very small embryonic-like stem cells (VSELs) and their immediate descendants ‘progenitor...

    Authors: Hiren Patel, Deepa Bhartiya, Seema Parte, Pranesh Gunjal, Snehal Yedurkar and Mithun Bhatt
    Citation: Journal of Ovarian Research 2013 6:52
  8. It is known that the new membrane-bound estrogen receptor GPER-1 acts suppressive in breast cancer cells and its expression decreases during disease ... to evaluate the GPER-1 expression in ovarian cancer and its...

    Authors: Tanja Ignatov, Saskia Modl, Maike Thulig, Christine Weißenborn, Oliver Treeck, Olaf Ortmann, AC Zenclussen, Serban Dan Costa, Thomas Kalinski and Atanas Ignatov
    Citation: Journal of Ovarian Research 2013 6:51
  9. Cancer stem cells (CSCs) are believed to be ‘seed cell’ in cancer recurrence and metastasis. MicroRNAs (miRNAs) can ... EMT, tumorigenicity and metastasis of epithelial ovarian cancer (EOC) CSCs.

    Authors: Dengyu Chen, Yunxia Zhang, Jing Wang, Junsong Chen, Cuiping Yang, Kai Cai, Xiaoying Wang, Fangfang Shi and Jun Dou
    Citation: Journal of Ovarian Research 2013 6:50
  10. While metastasis ranks among the most lethal of all cancer-associated processes, on the molecular level, ... , the lack of unambiguous confirmatory evidence in cancer patients has led to persistent challenges to....

    Authors: Loukia N Lili, Lilya V Matyunina, L DeEtte Walker, Stephen L Wells, Benedict B Benigno and John F McDonald
    Citation: Journal of Ovarian Research 2013 6:49
  11. Surgery is the cornerstone for clinical management of patients with borderline ovarian tumors (BOT). As these patients have an excellent overall prognosis, perioperative morbidity is the critical point for dec...

    Authors: Fabian Trillsch, Jan David Ruetzel, Uwe Herwig, Ulrike Doerste, Linn Woelber, Donata Grimm, Matthias Choschzick, Fritz Jaenicke and Sven Mahner
    Citation: Journal of Ovarian Research 2013 6:48
  12. VEGF may play a role in the pathogenesis of cancer disease, for example in cell growth, ... and the established tumor marker CA125 in ovarian cancer patients (100) as compared to control...

    Authors: Sławomir Ławicki, Grażyna Ewa Będkowska, Ewa Gacuta-Szumarska and Maciej Szmitkowski
    Citation: Journal of Ovarian Research 2013 6:45
  13. Endometriosis is frequently associated with high levels of CA125. This marker is therefore not useful for discriminating ovarian endometrioma from ovarian malignancy. The aim of this study was to establish a pane...

    Authors: Emanuela Anastasi, Teresa Granato, Renato Falzarano, Paola Storelli, Adele Ticino, Luigi Frati, Pierluigi Benedetti Panici and Maria Grazia Porpora
    Citation: Journal of Ovarian Research 2013 6:44
  14. Leydig cell tumours represent more than 75% of all testosterone-secreting ovarian masses. These benign tumours are frequently occult or very small, but cause dramatic virilization. Chronic hyperandrogenism can al...

    Authors: Giovanna Saraceno, Valeria Barresi, Francesco Trimarchi and Salvatore Cannavo
    Citation: Journal of Ovarian Research 2013 6:43
  15. Approximately one third of women diagnosed with ovarian cancer is 70 years or older. Information on...

    Authors: Fabian Trillsch, Linn Woelber, Christine Eulenburg, Ioana Braicu, Sandrina Lambrechts, Radoslav Chekerov, Els van Nieuwenhuysen, Paul Speiser, Alain Zeimet, Dan Cacsire Castillo-Tong, Nicole Concin, Robert Zeillinger, Ignace Vergote, Sven Mahner and Jalid Sehouli
    Citation: Journal of Ovarian Research 2013 6:42
  16. Malignant tumors are the single most common cause of death and the mortality rate of ovarian cancer is the highest among gynecological disorders. The ... by complete recovery; however, the activity of cancer cell...

    Authors: Chi-Chang Chang, Chao-Ming Hung, Yun-Ru Yang, Mon-Juan Lee and Yi-Chiang Hsu
    Citation: Journal of Ovarian Research 2013 6:41
  17. Our work has been carried out in the context of the therapeutic failure in ovarian carcinoma, which remains the leading cause of death by gynecologic malignancy. In these tumours, recurrence and subsequent acquir...

    Authors: Julie Tomasina, Aurélie Malzert-Freon, Florence Giffard, Emilie Brotin, Marie-Hélène Louis, Edwige Abeilard, Sylvain Rault, Pascal Gauduchon and Laurent Poulain
    Citation: Journal of Ovarian Research 2013 6:38
  18. Vitamin D deficiency and vitamin D receptor (VDR) gene polymorphism, FokI..., is reported to increase the risk of many cancers. Role of vitamin D and its receptor polymorphisms in ovarian cancer has not been clea...

    Authors: Sudhesna Mohapatra, Alpana Saxena, Gauri Gandhi, Bidhan Chandra Koner and Prakash Chandra Ray
    Citation: Journal of Ovarian Research 2013 6:37
  19. The polycystic ovary syndrome (PCOS) is a complex and heterogeneous endocrine condition characterized by hyperandrogenism, hyperinsulinemia, insulin resistance and chronic anovulation. Regulation and interacti...

    Authors: Md Munir Hossain, Mingju Cao, Qi Wang, Ji Young Kim, Karl Schellander, Dawit Tesfaye and Benjamin K Tsang
    Citation: Journal of Ovarian Research 2013 6:36
  20. A diagnosis of advanced ovarian cancer is the beginning of a long and ... half of the individuals undergoing therapy for advanced cancer will succumb to the disease, or consequences ... -fluorouracil, and doxorub...

    Authors: Kellie S Rath, Georgia A McCann, David E Cohn, Brian K Rivera, Periannan Kuppusamy and Karuppaiyah Selvendiran
    Citation: Journal of Ovarian Research 2013 6:35
  21. Metastatic neoplasms to the ovary often cause diagnostic problems, in particular those large ovarian masses mimicking primary tumors. Most of these tumors arise from digestive system or breast, while 37-year-old ...

    Authors: Nunzia Simona Losito, Cono Scaffa, Monica Cantile, Gerardo Botti, Raffaele Costanzo, Angela Manna, Renato Franco and Stefano Greggi
    Citation: Journal of Ovarian Research 2013 6:34
  22. Currently, cryopreservation of oocytes, embryos and ovarian tissue is considered the basis of fertility preservation programs for women with cancer and other diseases who are rendered sterile...

    Authors: Justo Callejo, Cristina Salvador, Santiago González-Nuñez, Laura Almeida, Luciano Rodriguez, Laura Marqués, Ana Valls and José Maria Lailla
    Citation: Journal of Ovarian Research 2013 6:33
  23. The capacity of nadir CA-125 levels to predict the prognosis of epithelial ovarian cancer remains controversial. This study aimed to explore ... ) in patients with high-grade serous ovarian cancer (HG-SOC) from t...

    Authors: Xia Xu, Yan Wang, Fang Wang, Lizhou Jia, Yiqin Zhou, Fei Deng, Junwei Qu, Bifang Zhou, Aifeng Meng, Bole Fu, Xiaoxiang Chen, Zhiying Qian and Jinhua Wang
    Citation: Journal of Ovarian Research 2013 6:31
  24. Oocyte in vitro maturation (IVM) and cryopreservation at the time of routine ovarian tissue freezing may be offered to cancer patients as an additional option for fertility...

    Authors: Patrick Imesch, David Scheiner, Min Xie, Daniel Fink, Erwin Macas, Raghvendra Dubey and Bruno Imthurn
    Citation: Journal of Ovarian Research 2013 6:30
  25. Evaluate and compare the utility of serum folate receptor alpha (FRA) and megakaryocyte potentiating factor (MPF) determinations relative to serum CA125, mesothelin (MSLN) and HE4 for the diagnosis of epithelial ...

    Authors: Daniel J O’Shannessy, Elizabeth B Somers, Leslie M Palmer, Robert P Thiel, Pankaj Oberoi, Ryan Heath and Lisa Marcucci
    Citation: Journal of Ovarian Research 2013 6:29
  26. This study aimed to investigate an unusual case of immature ovarian teratoma with onset of mature glial cells implanted on the contralateral ovary, a challenge in the diagnosis of the second ovarian tumor. We ...

    Authors: Ancuta Gheorghisan-Galateanu, Dana Cristina Terzea, Mara Carsote and Catalina Poiana
    Citation: Journal of Ovarian Research 2013 6:28
  27. Leiomyosarcoma of the rectum is a very rare mesenchymal tumor. Because of its rarity, its diagnosis, treatment, and pathology often present challenges to the clinician. The characteristics of this tumor, such ...

    Authors: Yung-Taek Ouh, Jin Hwa Hong, Kyung-Jin Min, Kyeong-A So and Jae Kwan Lee
    Citation: Journal of Ovarian Research 2013 6:27
  28. High-grade serous ovarian cancers are a distinct histological subtype of ovarian cancer often characterised by a dysfunctional BRCA/Fanconi...BRCA1 and BRCA2...genes and occur predominantly in high-grade serous cancer

    Authors: Thomas Mikeska, Kathryn Alsop, Gillian Mitchell, David DL Bowtell and Alexander Dobrovic
    Citation: Journal of Ovarian Research 2013 6:26
  29. Platinum drugs, including cisplatin, are a frontline therapeutic in ovarian cancer treatment and acquired resistance to these agents is a major contributor to ovarian cancer morbidity and mortality. In this study...

    Authors: Matthew J Schultz, Amanda F Swindall, John W Wright, Elizabeth S Sztul, Charles N Landen and Susan L Bellis
    Citation: Journal of Ovarian Research 2013 6:25
  30. It has already been found that very small embyronic-like stem cells (VSELs) are present in adult human tissues and organs. The aim of this study was to find if there exists any similar population of cells in c...

    Authors: Irma Virant-Klun, Martin Stimpfel, Branko Cvjeticanin, Eda Vrtacnik-Bokal and Thomas Skutella
    Citation: Journal of Ovarian Research 2013 6:24
  31. Although agonistic autoantibodies against type-1 angiotensin-II receptor (AT1-AA) are frequently detected in women with preeclampsia, the clinical significance of AT1-AA in association with epithelial ovarian cancer

    Authors: Li Song, Su-Li Zhang, Ke-Hua Bai, Jie Yang, Hai-Yan Xiong, Xiao Li, Teng Liu and Hui-Rong Liu
    Citation: Journal of Ovarian Research 2013 6:22
  32. Ovarian cancer has the highest mortality rate of all gynaecologic cancers. Faced with poor prognoses, stressful treatment ... of life. Frequently reported side effects include cancer-related fatigue, peripheral n...

    Authors: Shalini H Moonsammy, Crissa L Guglietti, Daniel Santa Mina, Sarah Ferguson, Jennifer L Kuk, Sara Urowitz, David Wiljer and Paul Ritvo
    Citation: Journal of Ovarian Research 2013 6:21
  33. Cryopreserved ovarian cortical tissue acts as a source of primordial follicles (PF) which can either be auto-transplanted or cultured in vitro...to obtain mature oocytes. This offers a good opportunity to attain ...

    Authors: Seema Parte, Deepa Bhartiya, Dhananjay D Manjramkar, Anahita Chauhan and Amita Joshi
    Citation: Journal of Ovarian Research 2013 6:20
  34. Epithelial ovarian cancer (EOC) is the most lethal gynecological cancer. Several hospitals throughout the region provide primary...

    Authors: Vincenzo Dario Mandato, Martino Abrate, Pierandrea De Iaco, Debora Pirillo, Gino Ciarlini, Maurizio Leoni, Giuseppe Comerci, Alessandro Ventura, Bruno Lenzi, Andrea Amadori, Federica Rosati, Ruby Martinello, Rossana De Palma, Chiara Ventura, Laura Maria Beatrice Belotti, Debora Formisano…
    Citation: Journal of Ovarian Research 2013 6:19
  35. Ovarian carcinoma is the leading cause of cancer death worldwide among gynecological malignancies, and the ... cases are related with recurrence and chemoresistance. Cancer stem cells (CSCs) are believed to ... o...

    Authors: Young Tae Park, Ju-yeon Jeong, Mi-jung Lee, Kwang-il Kim, Tae-Heon Kim, Young-do Kwon, Chan Lee, Ok Jun Kim and Hee-Jung An
    Citation: Journal of Ovarian Research 2013 6:18
  36. There is no information in the literature on the impact of changes in quality of life (QoL) scores on prognosis in ovarian cancer. We investigated whether changes in QoL during treatment could predict survival in...

    Authors: Digant Gupta, Donald P Braun, Edgar D Staren and Maurie Markman
    Citation: Journal of Ovarian Research 2013 6:17
  37. Successful egg cryopreservation has many potential benefits to a variety of patients. However, a superior standard protocol describing all aspects of oocyte cryopreservation has not yet been identified. Oocyte...

    Authors: Cassie T Wang, Lifeng Liang, Craig Witz, Dan Williams, Jason Griffith, Josh Skorupski, Ghassan Haddad, Jimmy Gill and Weihua Wang
    Citation: Journal of Ovarian Research 2013 6:15
  38. There is no consensus regarding the management of ovarian cancer patients, who have shown complete clinical response ... (CCR) to primary therapy and have rising cancer antigen CA-125 levels but have no...

    Authors: Fang Wang, Yanfen Ye, Xia Xu, Xuehui Zhou, Jinhua Wang and Xiaoxiang Chen
    Citation: Journal of Ovarian Research 2013 6:14
  39. The massive edema of ovary, with or without fibromatosis, is a rare tumor-like entity characterized by an increase in volume of one or both ovaries for accumulation of edema fluid in the stroma that separates ...

    Authors: Rossella De Cecio, Monica Cantile, Nicola Fortunato, Annarosaria De Chiara, Nunzia Simona Losito, Renato Franco and Gerardo Botti
    Citation: Journal of Ovarian Research 2013 6:13
  40. The ovarian surface epithelium responds to cytokines and hormonal cues to initiate proliferation and migration following ovulation. Although insulin and IGF are potent proliferative factors for the ovarian surfac...

    Authors: Shelby M King, Dimple A Modi, Sharon L Eddie and Joanna E Burdette
    Citation: Journal of Ovarian Research 2013 6:12
  41. This cell line has been growing well for 232 months and subcultured more than 50 times. Monolayer cultured cells were polygonal in shape, showing a pavement-like arrangement and a tendency to stack without contac...

    Authors: Takashi Yamada, Takayoshi Kanda, Hiroshi Mori, Kaname Shimokawa, Mitsuo Kagawa and Yuro Shibayama
    Citation: Journal of Ovarian Research 2013 6:8

Annual Journal Metrics

  • 2022 Citation Impact
    4.0 - 2-year Impact Factor
    4.7 - 5-year Impact Factor
    1.118 - SNIP (Source Normalized Impact per Paper)
    0.965 - SJR (SCImago Journal Rank)

    2023 Speed
    10 days submission to first editorial decision for all manuscripts (Median)
    138 days submission to accept (Median)

    2023 Usage 
    1,114,260 downloads
    475 Altmetric mentions

New Content ItemEditor-in-Chief Dr Sham Kakar has been recognised as being among the top 2% most-cited researchers in the world. Please join us in celebrating this amazing achievement. 

Read more here.